EUVIMEDEUVIMED entdecken
Crossref

Thrombus architecture is influenced by the antiplatelet loading treatment in patients with acute myocardial infarction

Tobias Harm, Dominik Rath, Klaus-Peter Kreisselmeier, Livia Baas, Carolin Prang, Sarah Gekeler, Stephen Schröder, Meinrad Paul Gawaz, Tobias Geisler, Iris Irmgard Müller, Karin Anne Lydia Müller

Thrombosis Research · 2023-10 · 230 · 45-54

DOI: 10.1016/j.thromres.2023.08.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis Research, 2023-10. Verfasst von Tobias Harm und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Angiology, University Hospital Tübingen, Eberhard Karls University Tübingen, Otfried-Müller-Straße 10, 72076 Tübingen, G…. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, Myocardial Infarction, Thrombosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung., Daiichi Sankyo Europe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intracoronary thrombus formation is a main cause of acute myocardial infarction triggered by platelet activation. However, there are no data on the impact of different treatment strategies with antiplatelet agents before percutaneous coronary intervention (PCI) on histological characteristics of thrombus formation. OBJECTIVE: In this study, we investigate the impact of preinterventional administration of the P2Y12-inhibitors clopidogrel and prasugrel on thrombus composition, highlighting significant changes associated with the antiplatelet pre-treatment. METHODS: We prospectively enrolled 104 consecutive patients with ST-segment elevation myocardial infarction (STEMI) undergoing immediate PCI and thrombus aspiration by immunohistochemical staining along with RNA-sequencing employing Nanostring analysis. Fifty-two patients were treated with either prasugrel loading (60 mg) or clopidogrel loading (600 mg) prior to PCI, respectively. RESULTS: In Patients with STEMI, intracoronary thrombus architecture was significantly altered between patients pre-treated with prasugrel when compared to clopidogrel. Fibrin content of thrombi was significantly decreased (41.8 % versus 66.7 %, p = 0.009) after pre-treatment with prasugrel compared to clopidogrel. Furthermore, levels of MPO positive cells in intracoronary thrombi were significantly decreased in patients with prasugrel pre-treatment (90.5 versus 201.1, p = 0.014) indicating an association of antiplatelet pre-treatment and the inflammatory responses during thrombus formation. Most strikingly, we observed significant differences among both pre-treatment groups regarding altered RNA expression and signaling pathways of thrombo-inflammatory processes within the thrombotic material, which were independently associated with antiplatelet strategies. CONCLUSIONS: Our study elucidates the impact of antiplatelet pre-treatment on thrombus remodeling and architecture, thereby lowering the risk of recurrent adverse cardiovascular events in prasugrel-treated patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ST Elevation Myocardial InfarctionPercutaneous Coronary InterventionMyocardial InfarctionThrombosisHumansPrasugrel HydrochlorideClopidogrelTreatment OutcomePlatelet Aggregation InhibitorsRNA

Stichwörter der Autor:innen

Antiplatelet treatmentFibrinInflammationMyocardial infarctionThrombus architecture

Substanzen

Prasugrel HydrochlorideClopidogrelPlatelet Aggregation InhibitorsRNA

Autor:innen und Institutionen

  • Department of Cardiology and Angiology, University Hospital Tübingen, Eberhard Karls University Tübingen, Otfried-Müller-Straße 10, 72076 Tübingen, Germany.
  • Department of Cardiology and Angiology, Klinik am Eichert, Eichertstraße 3, 73035 Göppingen, Germany.
  • Department of Cardiology and Angiology, University Hospital Tübingen, Eberhard Karls University Tübingen, Otfried-Müller-Straße 10, 72076 Tübingen, Germany. Electronic address: tobias.geisler@med.uni-tuebingen.de.

Förderung

  • Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.
  • Daiichi Sankyo Europe

Zitieren

APA

Harm, T., Rath, D., Kreisselmeier, K. P., Baas, L., Prang, C., Gekeler, S., Schröder, S., Gawaz, M. P., Geisler, T., Müller, I. I., & Müller, K. A. L. (2023). Thrombus architecture is influenced by the antiplatelet loading treatment in patients with acute myocardial infarction. Thrombosis Research, 230, 45-54. https://doi.org/10.1016/j.thromres.2023.08.004

Vancouver

Harm T, Rath D, Kreisselmeier KP, Baas L, Prang C, Gekeler S, et al. Thrombus architecture is influenced by the antiplatelet loading treatment in patients with acute myocardial infarction. Thrombosis Research. 2023;230:45-54. doi:10.1016/j.thromres.2023.08.004

BibTeX
@article{Harm2023,
  author = {Harm, Tobias and Rath, Dominik and Kreisselmeier, Klaus-Peter and Baas, Livia and Prang, Carolin and Gekeler, Sarah and Schröder, Stephen and Gawaz, Meinrad Paul and Geisler, Tobias and Müller, Iris Irmgard and Müller, Karin Anne Lydia},
  title = {Thrombus architecture is influenced by the antiplatelet loading treatment in patients with acute myocardial infarction},
  journal = {Thrombosis Research},
  year = {2023},
  volume = {230},
  pages = {45--54},
  doi = {10.1016/j.thromres.2023.08.004}
}
Kostenlos starten →